S Chalkias M R Mackenzie C Gay C Dooley F M Marty R B Moss T Li R L Routh S R Walsh C S Tan
10.1111/tid.12177
Transpl Infect Dis
2014 Feb;16(1):141-4.
das181 hsct mechanical ventilation parainfluenza
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/24383501/
Antiviral Agents / therapeutic use Graft vs Host Disease / prevention & control Hematopoietic Stem Cell Transplantation Immunocompromised Host Immunosuppressive Agents / therapeutic use Paramyxoviridae Infections / drug therapy Pneumonia, Viral / drug therapy Recombinant Fusion Proteins / therapeutic use
Antiviral Agents / therapeutic use Graft vs Host Disease / prevention & control Hematopoietic Stem Cell Transplantation Immunocompromised Host Immunosuppressive Agents / therapeutic use Paramyxoviridae Infections / drug therapy Pneumonia, Viral / drug therapy Recombinant Fusion Proteins / therapeutic use Case Reports Aged Female Humans Male Middle Aged Paramyxoviridae Infections / complications Paramyxoviridae Infections / immunology Pneumonia, Viral / complications Pneumonia, Viral / immunology Prednisone / therapeutic use Respiration, Artificial Respiratory Insufficiency / etiology Respiratory Insufficiency / therapy Sirolimus / therapeutic use Treatment Outcome Antiviral Agents Immunosuppressive Agents Recombinant Fusion Proteins oplunofusp Prednisone Sirolimus
PMC4469988
24383501
DAS181 treatment of hematopoietic stem cell transplant patients with parainfluenza virus lung disease requiring mechanical ventilation
2014